Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Virtual Reality Decreases Child Anxiety and Pain as Well as Caregiver Anxiety and Pain Perception During Orthopaedic Clinic Office Procedures [NA]
A terminated clinical trial evaluating virtual reality to reduce anxiety and pain in children and caregiver anxiety/pain during orthopaedic …
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: Ibuprofen to Decrease Opioid Use and Post-operative Pain Following Unilateral Inguinal Herniorrhaphy [Phase 3]
Phase 3 trial investigating ibuprofen to reduce opioid use and post-operative pain after unilateral inguinal herniorrhaphy; study terminated…
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department [Phase 3]
A Phase 3 trial evaluating the efficacy of a lidocaine patch for acute musculoskeletal pain in emergency department settings has completed w…
-
CLINICAL_TRIALS trial_result · 2024-03-22Clinical Trial Update: A Safety, Tolerability, Pharmacokinetics (PK) and Target Engagement (TE) Study of GSK3858279 in Healthy Participants and Evaluation of the Efficacy of Repeat Doses in Participants With Osteoarthritis (OA) [Phase 1]
Phase 1 trial evaluating safety, tolerability, PK, and target engagement of GSK3858279 in healthy participants with exploratory efficacy ass…
-
FDA approval · 2024-03-20FDA Approved: BUPRENORPHINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for buprenorphine from Actavis Pharma, Inc. under ANDA090819, granting regulatory clearance for this…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-03-20FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)
FDA approved a supplemental application for buprenorphine hydrochloride from PAI Holdings/PAI Pharma. This approval updates the product’s la…
-
FDA approval · 2024-03-19FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Aurolife Pharma, LLC)
FDA approved a supplemental application for Methadone Hydrochloride from Aurolife Pharma, authorizing a generic formulation of the opioid me…
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: Influence of Epidural Analgesia in Elective Laparoscopic Colorectal Resections [Phase 4]
Phase 4 clinical trial update evaluating the influence of epidural analgesia in elective laparoscopic colorectal resections.
-
FDA approval · 2024-03-15FDA Approved: PROLATE — Supplemental Application (Forte Bio-Pharma LLC)
FDA approved a supplemental application for PROLATE (oxycodone hydrochloride and acetaminophen) submitted by Forte Bio-Pharma LLC.
-
FDA approval · 2024-03-15FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals’ supplemental ANDA for oxycodone and acetaminophen tablets, enabling the marketing of the generic product…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Integrated Supported Biopsychosocial Self-Management for Back Related Leg Pain [NA]
A completed clinical trial evaluating integrated biopsychosocial self-management for back-related leg pain, including low back pain and scia…
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis [Phase 2]
Phase 2 study update for tanezumab in moderate to severe pain due to Schwannomatosis; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Postoperative Pain Control & Relief in Neonates [Phase 4]
Phase 4 clinical trial update on postoperative pain control and relief in neonates has been terminated.
-
FDA approval · 2024-03-12FDA Approved: HYDROMORPHONE HYDROCHLORIDE — Supplemental Application (Trigen Laboratories, LLC)
The FDA approved a supplemental application for hydromorphone hydrochloride (generic) from Trigen Laboratories, LLC, authorizing a regulator…
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Safety and Efficacy Evaluation of S (+) - Ketamine in Children [Phase 4]
A Phase 4 clinical trial assessing safety and efficacy of S(+)-ketamine in children for acute postoperative analgesia and related outcomes i…
-
FDA approval · 2024-03-06FDA Approved: ACETAMINOPHEN AND CODEINE PHOSPHATE — Supplemental Application (Aurolife Pharma, LLC)
FDA approved a supplemental application for Acetaminophen and Codeine Phosphate manufactured by Aurolife Pharma, LLC.
-
FDA approval · 2024-03-04FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for an oxycodone hydrochloride and acetaminophen product submitted by SpecGx LLC.
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: Collaborative Care for Opioid Dependence And Pain Pilot Study [NA]
A pilot study investigating collaborative care for individuals with opioid dependence and chronic pain was terminated, with results posted i…
-
FDA approval · 2024-02-28FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Epic Pharma, LLC)
The FDA approved a supplemental application for the oxycodone and acetaminophen product from Epic Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Ketamine Versus Magnesium as Analgesic Adjuvants in Pediatric Adenotonsillectomy [Phase 4]
Phase 4 trial comparing ketamine and magnesium as analgesic adjuvants in pediatric adenotonsillectomy has completed.
-
FDA approval · 2024-02-27FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for Hydrocodone Bitartrate and Acetaminophen by PAI Holdings, LLC dba PAI Pharma under ANDA 0408…
-
FDA approval · 2024-02-27FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Eywa Pharma Inc)
FDA approved Eywa Pharma Inc's supplemental application for Hydrocodone Bitartrate and Acetaminophen.
-
CLINICAL_TRIALS research · 2024-02-26Clinical Trial Update: Electrically Evoked Compound Action Potentials Human Observation Medtronic Algorithm Comparison Study [NA]
A completed Medtronic-sponsored clinical trial comparing algorithms for electrically evoked compound action potentials in chronic pain patie…
-
FDA approval · 2024-02-26FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Epic Pharma, LLC)
The FDA granted supplemental approval for a generic oxycodone/acetaminophen product from Epic Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: Effect of High-dose Naloxone Infusion on Pain and Hyperalgesia in Patients Following Groin-Hernia Repair. [Phase 2]
Phase 2 trial studying high-dose naloxone infusion for pain and hyperalgesia after groin-hernia repair; completed.